Trial Profile

Safety and Effect of Mirapex (Pramipexole) Tablet Among Korean RLS.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pramipexole (Primary)
Indications Restless legs syndrome
Focus Adverse reactions
Sponsors Boehringer Ingelheim

Most Recent Events

03 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
01 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
06 Aug 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com